表紙
市場調査レポート

眼炎症:世界の治験動向

Ocular Inflammation Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 338377
出版日 ページ情報 英文 98 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
眼炎症:世界の治験動向 Ocular Inflammation Global Clinical Trials Review, H2, 2015
出版日: 2015年07月24日 ページ情報: 英文 98 Pages
概要

当レポートでは、眼炎症の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 眼炎症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:眼科疾患治療薬の治験における眼炎症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:眼科疾患治療薬の治験における眼炎症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

眼炎症治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Novartis AG
    • Valeant Pharmaceuticals International, Inc.
    • XOMA Corporation
    • Alcon, Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Sirion Therapeutics, Inc. (Inactive)
    • Allergan Plc
    • SIFI S.p.A
    • Celgene Corporation
  • 代表的な研究機関・病院の治験の概要
    • National Eye Institute
    • Oregon Health & Science University
    • Medical University of Vienna
    • Moorfields Eye Hospital NHS Foundation Trust
    • The Johns Hopkins University
    • University of California, San Francisco
    • Capital Medical University
    • Duke University
    • Erasmus MC
    • Isfahan University of Medical Sciences

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2791CTIDB

GlobalData's clinical trial report, "Ocular Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Ocular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ocular Inflammation
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ocular Inflammation
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ocular Inflammation Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Ocular Inflammation
      • Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • XOMA Corporation
      • Clinical Trial Overview of XOMA Corporation
      • Alcon, Inc.
      • Clinical Trial Overview of Alcon, Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Sirion Therapeutics, Inc. (Inactive)
      • Clinical Trial Overview of Sirion Therapeutics, Inc. (Inactive)
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
      • SIFI S.p.A
      • Clinical Trial Overview of SIFI S.p.A
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Moorfields Eye Hospital NHS Foundation Trust
      • Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Capital Medical University
      • Clinical Trial Overview of Capital Medical University
      • Duke University
      • Clinical Trial Overview of Duke University
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirion Therapeutics, Inc. (Inactive), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by SIFI S.p.A, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015*

List of Figures

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top